P Bierstedt. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Antifibrinolytic Agents/therapeutic useAprotinin/therapeutic useBlood Coagulation Disorders/drug therapyBlood Coagulation Disorders/enzymologyBlood Coagulation Disorders/etiologyBlood Coagulation Disorders/metabolismBlood Coagulation Disorders/prevention & controlExtracorporeal Circulation/adverse effectsFibrinolysin/pharmacologyHeparin/pharmacologyHumansProtamines/metabolism
Substances: See more » Antifibrinolytic AgentsProtaminesHeparinAprotininFibrinolysin
Year: 1968 PMID: 4249456 DOI: 10.1007/bf02453906
Source DB: PubMed Journal: Langenbecks Arch Chir ISSN: 0023-8236